Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease? (Q38164892)

30 August 2017

title

Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease? (English)

1 reference

30 August 2017

0 references

0 references

1 reference

1 reference

1

Brit Mollenhauer

1 reference

30 August 2017

publication date

1 January 2014

1 reference

Parkinsonism and Related Disorders

30 August 2017

published in

1 reference

30 August 2017

volume

20 Suppl 1

1 reference

30 August 2017

page(s)

S76-9

1 reference

A responsive outcome for Parkinson's disease neuroprotection futility studies

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Genetics of Parkinson disease: paradigm shifts and future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Neurodegeneration in Parkinson disease: moving Lewy bodies out of focus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

CSF α-synuclein does not differentiate between parkinsonian disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Salivary tau species are potential biomarkers of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2813%2970020-8

7 January 2021

10.1016/S1353-8020(13)70020-8

Identifiers

DOI

1 reference

30 August 2017

1 reference